Filing Flows › Cosmos Health (COSM) › Guidance & outlook
Cosmos Health (COSM) guidance and outlook
Cosmos Health (COSM) raised its guidance on Oct 22, 2026: Revenue $15.0M for Q4 2026; Gross profit $10.5M for Q4 2026; Gross profit +70% for Q4 2026; Gross margin 70% for Q4 2026.
Latest guidance
| Metric | Period | Range | Change |
|---|---|---|---|
| Revenue | Q4 2026 | $15.0M | new |
| Gross profit | Q4 2026 | $10.5M | new |
| Revenue | Q4 2026 | $11.5M | raised |
| Gross profit | Q4 2026 | +70% | new |
| Revenue | Q4 2026 | +42% | new |
| Gross margin | Q4 2026 | 70% | new |
| Gross profit | Q4 2026 | $10.5M | new |
| Revenue | FY2026 | $200K | raised |
From the earnings release filed Oct 22, 2026 (8-K on EDGAR).
Cosmos Health's latest quarter
Cosmos Health, Q2 2026: revenue $19.0M (+29% year over year), operating margin -15.4%, net loss $6.1M, operating cash flow −$1.7M. The chart follows the revenue to costs, profit and cash.
Questions
Did Cosmos Health raise or lower its guidance?
Cosmos Health (COSM) raised its guidance on Oct 22, 2026: Revenue $15.0M for Q4 2026; Gross profit $10.5M for Q4 2026; Gross profit +70% for Q4 2026; Gross margin 70% for Q4 2026.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.